Finance

Beta
Lists
Equity sectors
Symbols
Symbols
Price
Change
% Change
Trend
Prev Close
Open
High
Low
Volume
Mkt Cap
SIXB
Materials
SIXB
Materials
SIXB
+0.99%
1,093.81
+10.77
+0.99%
—1,083.041,082.631,099.011,080.59——
SIXC
Communications
SIXC
Communications
SIXC
+1.06%
608.77
+6.39
+1.06%
—602.38602.38609.75599.75——
SIXE
Energy
SIXE
Energy
SIXE
+0.96%
1,254.81
+11.98
+0.96%
—1,242.831,229.311,258.881,220.51——
SIXI
Industrials
SIXI
Industrials
SIXI
+2.76%
1,761.11
+47.29
+2.76%
—1,713.821,715.471,763.111,715.47——
SIXM
Financials
SIXM
Financials
SIXM
+0.40%
642.58
+2.59
+0.40%
—639.99636.98644.04631.81——
SIXR
Staples
SIXR
Staples
SIXR
+1.63%
851.13
+13.67
+1.63%
—837.46840.30852.55840.30——
SIXRE
Real estate
SIXRE
Real estate
SIXRE
+1.76%
217.98
+3.76
+1.76%
—214.22214.22218.25214.05——
SIXT
Technology
SIXT
Technology
SIXT
+0.23%
3,211.83
+7.45
+0.23%
—3,204.383,215.043,217.443,159.90——
SIXU
Utilities
SIXU
Utilities
SIXU
+2.55%
948.98
+23.60
+2.55%
—925.38927.91949.76927.91——
SIXV
Health care
SIXV
Health care
SIXV
+2.20%
1,474.52
+31.81
+2.20%
—1,442.711,443.011,477.901,443.01——
SIXY
Discretionary
SIXY
Discretionary
SIXY
+1.30%
2,392.12
+30.78
+1.30%
—2,361.342,391.002,399.182,354.52——
Q4 2026 earnings • in 4 days
See details
EMCURE:NSE
Emcure Pharmaceuticals Ltd
₹1,695.50
-1.99%
(-34.40) 1D
Apr 30, 3:30:00 PM GMT+5:30  ·   INR
All symbols
SymbolPriceChange% Change
Generating top insights for EMCURE...
Open
₹1,730.00
High
₹1,734.90
Low
₹1,660.90
Mkt. cap
319.27B
Avg. vol.
284.39K
Volume
278.78K
Dividend
0.18%
Quarterly dividend
₹0.75
Ex dividend date
Aug 14, 2025
P/E ratio
36.93
52-wk high
₹1,769.00
52-wk low
₹983.00
EPS
₹45.91
No. of employees
7K
News stories
From sources across the web
Profile
Emcure Pharmaceuticals Limited is an Indian multinational pharmaceutical company, headquartered in Pune. Emcure's product portfolio includes tablets, capsules and injectables. The company produces gynaecology, cardiovascular, oncology and blood therapeutic drugs, HIV antivirals and other anti-infectives, and vitamins and minerals. Wikipedia
About Emcure Pharmaceuticals Ltd
CEOSatish Ramanlal Mehta
Employees6.73K
FoundedApr 16, 1981
Headquarters-
SectorPharmaceutical industry
Websiteemcure.com
Next call in 4 days
Tue, May 5, 6:00 AM
Fiscal Period
Q4 2026
Normalized EPS / Estimate
-/ (14.70 est.)INR
Revenue / Estimate
-/ (24.20B est.)INR
Fiscal Q4 2026 earnings call
Waiting for the earnings call
At a glance: upcoming earningsInsights from the latest news and reports
Previous reportsAll values in INR
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in INR
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Revenue
21.16B
21.01B
22.70B
23.63B
Cost of goods sold
9.68B
8.02B
8.90B
9.62B
Cost of revenue
9.68B
8.02B
8.90B
9.62B
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
6.53B
3.93B
3.85B
3.87B
Operating expense
8.55B
9.94B
10.46B
10.46B
Total operating expenses
18.23B
17.96B
19.35B
20.08B
Operating income
2.93B
3.04B
3.34B
3.55B
Other non operating income
-942.44M
36.96M
31.23M
18.53M
EBT including unusual items
2.61B
2.91B
3.41B
3.14B
EBT excluding unusual items
2.65B
2.94B
3.41B
3.52B
Income tax expense
633.76M
759.65M
900.47M
824.22M
Effective tax rate
24.32%
26.13%
26.37%
26.27%
Other operating expenses
1.05B
5.01B
5.57B
5.54B
Net income
1.89B
2.07B
2.43B
2.31B
Net profit margin
8.93%
9.85%
10.73%
9.75%
Earnings per share
10.38
11.06
12.85
13.67
Interest and investment income
156.33M
-
-
-
Interest expense
-
-267.55M
-325.42M
-379.75M
Net interest expenses
156.33M
-267.55M
-325.42M
-379.75M
Depreciation and amortization charges
968.37M
994.56M
1.05B
1.05B
EBITDA
3.75B
3.86B
4.37B
4.37B
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

My tasks
You haven't created a task yet
Your tasks will appear here. Schedule tasks and put Google Finance to work while you're away.
Templates
Watchlist briefing
A daily pre-market analysis of your watchlist
Upcoming Earnings
Upcoming earnings reports in the week
Abnormal Volatility & Volume
Volatility and volume early warning today
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer